The Effect of Mirror Therapy Applied to Stroke Patients on Motor-Sensory Status and Quality of Life
Launched by ATATURK UNIVERSITY · Apr 30, 2025
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a treatment called Mirror Therapy on stroke patients. The researchers want to find out if this therapy can help improve movement and sensation in patients, as well as enhance their overall quality of life. The trial will take place at Bilecik Training and Research Hospital and Bozüyük State Hospital from August 2024 to May 2025, and it will involve 350 participants. Those who qualify for the study must be at least 18 years old, have had a stroke for at least six days, and be able to communicate effectively.
During the trial, participants will be divided into two groups. One group will receive standard rehabilitation plus 30 minutes of Mirror Therapy four times a week for four weeks, while the other group will only get the standard rehabilitation. Assessments will be done before and after the treatment period to see how well each group improves. If participants are discharged before the four weeks are up, they will continue their treatment at home. This study aims to provide valuable insights into how Mirror Therapy can benefit stroke recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Being literate,
- • 2. Being over the age of 18,
- • 3. Having sufficient communication skills to answer oral and written questions and follow instructions,
- • 4. Having been diagnosed with a stroke and at least 6 days have passed since it occurred,
- • 5. Not having severe vision problems,
- • 6. Not having a vertigo problem,
- • 7. Not having been diagnosed with epilepsy,
- • 8. Upper extremity Stage 2 and above in Brunnstrom staging
- • 9. Lower extremity Stage 2 and above in Brunnstrom staging
- Exclusion Criteria:
- • 1. Being under 18 years of age
- • 2. Upper extremity Stage 2 and below in Brunnstrom staging
- • 3. In Brunnstrom staging, Lower extremity Stage 2 and below
About Ataturk University
Atatürk University, located in Erzurum, Turkey, is a prominent academic institution dedicated to advancing research and education across various disciplines. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative medical research aimed at improving patient outcomes and contributing to the global body of health knowledge. Committed to ethical standards and rigorous scientific methodologies, Atatürk University collaborates with healthcare professionals, researchers, and regulatory bodies to ensure the integrity and efficacy of its clinical trials, ultimately enhancing the quality of care and driving advancements in medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported